Patient-Reported Outcome Measures 2 Years After Standard and Distal Gastric Bypass-a Double-Blind Randomized Controlled Trial.

Marius Svanevik, Hilde Risstad, Tor-Ivar Karlsen, Jon A Kristinsson, Milada Cvancarova Småstuen, Ronette L Kolotkin, Torgeir T Søvik, Rune Sandbu, Tom Mala, Jøran Hjelmesæth

Journal: Obesity surgery 2018;28(3):606-614

PMID: 28865057

Plain Language Summary

plain language summary logo

Bariatric surgery may induce weight loss, improvement of weight-associated comorbidities, and improved health and well-being. The aim of the study is to compare the effects of standard and distal Rou-en-Y gastric bypass on obesity-specific health related quality of life, weight-related symptoms, eating behaviour, anxiety and depression. The study is a double-blind, parallel-group randomised controlled trial. The participants’ age ranged from 18 to 60 years of age with a BMI of 50 to 60 kg/m2. Results indicated improvements in most patient-reported outcome measures after both surgeries, but no significant difference between groups after surgery in relation to obesity-specific health related quality of life, weight-related symptoms, anxiety and depression, or eating behaviour. Authors conclude that both surgeries lead to sustained weight loss and improved health related quality of life 2 years after surgery in patients with a BMI 50-60kg/m2.

Abstract

BACKGROUND

The preferred surgical procedure for treating morbid obesity is debated. Patient-reported outcome measures (PROMs) are relevant for evaluation of the optimal bariatric procedure.

METHODS

A total of 113 patients with BMI from 50 to 60 were randomly assigned to standard (n = 57) or distal (n = 56) Roux-en-Y gastric bypass (RYGB). Validated PROMS questionnaires were completed at baseline and 2 years after surgery. Data were analyzed using mixed models for repeated measures and the results are expressed as estimated means and mean changes.

RESULTS

Obesity-related quality of life improved significantly after both procedures, without significant between-group differences (- 0.4 (95% CI = - 8.4, 7.2) points, p = 0.88, ES = 0.06). Both groups had significant reductions in the number of weight-related symptoms and symptom distress score, with a mean group difference (95% CI) of 1.4 (- 0.3, 3.3) symptoms and 5.0 (2.9. 12.8) symptom distress score points. There were no between-group differences for uncontrolled eating (22.0 (17.2-26.7) vs. 28.9 (23.3-34.5) points), cognitive restraint (57.4 (52.0-62.7) vs. 62.1 (57.9-66.2) points), and emotional eating (26.8 (20.5-33.1) vs. 32.6 (25.5-39.7) points). The prevalence of anxiety was 33% after standard and 25% after distal RYGB (p = 0.53), and for depression 12 and 9%, respectively (p = 0.76).

CONCLUSIONS

There were no statistically significant differences between standard and distal RYGB 2 years post surgery regarding weight loss, obesity-related quality of life, weight-related symptoms, anxiety, depression, or eating behavior.

TRIAL REGISTRATION

Clinical Trials.gov number NCT00821197.

Address: Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway. [email protected].; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. [email protected].; Department of Gastrointestinal Surgery, Vestfold Hospital Trust, Tønsberg, Norway. [email protected].; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Endocrinology, Morbid Obesity, and Preventive Medicine, Oslo University Hospital, Oslo, Norway.; Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway.; Department of Endocrinology, Morbid Obesity, and Preventive Medicine, Oslo University Hospital, Oslo, Norway.; Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway.; Oslo and Akershus University College of Applied Science, Oslo, Norway.; Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway.; Quality of Life Consulting, Durham, NC, USA.; Department of Endocrinology, Morbid Obesity, and Preventive Medicine, Oslo University Hospital, Oslo, Norway.; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway.; Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway.; Department of Gastrointestinal Surgery, Vestfold Hospital Trust, Tønsberg, Norway.; Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Patient Centred Factor

Physical Environment

Modifiable Lifestyle Factors

Jadad Score

Allocation Concealment

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.